Tavaborole
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 153 publications
Boron-Containing Drug Candidates in Clinical Trials.
Journal: Handbook of experimental pharmacology
Published: August 05, 2026
Boron-Based Bioisosteres in Medicinal Chemistry: Advances in Heterocycles and Therapeutic.
Journal: ChemMedChem
Published: June 03, 2026
On the mode of anti-C. albicans activity of a bis(benzoxaborole) analogue of tavaborole.
Journal: Future science OA
Published: April 28, 2026
Benzoxaborole-Based Inhibitors Block LexA Autocleavage and Suppress SOS-Dependent Adaptive Phenotypes in Escherichia coli.
Journal: Antibiotics (Basel, Switzerland)
Published: March 27, 2026
A targeted drug-repurposing strategy identifies Tavaborole (Kerydin) as a potent fungistatic agent against Candida auris.
Journal: Frontiers in microbiology
Published: March 14, 2026
Zn2+-Driven Tavaborole-Adenosine Hydrogel: A Strategy for Enhanced Solubility, Sustained Release, and Antifungal Efficacy.
Journal: Molecular pharmaceutics
Published: February 07, 2026
Telemedicine visits for new onychomycosis diagnoses result in fewer antifungal prescriptions than in-person care: A retrospective cohort study.
Journal: JAAD international
Published: January 21, 2026
Benzoxaborole and Beyond: The Emergence of Cyclic Hemiboronic Acids as a Versatile Chemotype in Medicine, Catalysis, and Materials.
Journal: Chemical reviews
Published: January 13, 2026
Recent advances in the synthesis and applications of oxaborole derivatives.
Journal: Organic & biomolecular chemistry
Published: January 13, 2026
Molecular modeling of 7-propanamide benzoxaboroles as CPSF3 inhibitors through docking-based 3D-QSAR and molecular dynamics simulations.
Journal: RSC advances
Published: December 30, 2025
Last Updated: 09/26/2026